Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
NDC 13107-073, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate, tablet, from Aurolife Pharma, LLC.
- Product NDC
- 13107-073
- Status
- Listed
- Labeler
- Aurolife Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202424
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/13107-073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROAMPHETAMINE SACCHARATE5 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE5 mg/1
- DEXTROAMPHETAMINE SULFATE5 mg/1
- AMPHETAMINE SULFATE5 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Central Nervous System Stimulation [PE]; Central Nervous System Stimulation [PE]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13107-073-01 | 13107007301 | 100 TABLET in 1 BOTTLE (13107-073-01) |
| 13107-073-05 | 13107007305 | 500 TABLET in 1 BOTTLE (13107-073-05) |
| 13107-073-25 | 13107007325 | 250 TABLET in 1 BOTTLE (13107-073-25) |
| 13107-073-50 | 13107007350 | 50 TABLET in 1 BOTTLE (13107-073-50) |
| 13107-073-99 | 13107007399 | 1000 TABLET in 1 BOTTLE (13107-073-99) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a582d57f-d191-4ca5-b105-585b2d8a0e3eNADAC price for package 13107007301
GET /v1/drugs/nadac/13107007301
Use it
Look up 13107-073 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13107-073 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13107-073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.